🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
12 weeks open label with Otezla® and NUVB, followed by 6 month double blind...
Status
Completed
Location
Psoriasis Treatment Center of Central New Jersey
Start Date
2015-05-28
Trial ID
NCT02412644
Treatments Being Tested
The purpose of this study is to determine whether apremilast is safe and ef...
Status
Completed
Location
Arizona Research Center
Start Date
2010-12-09
Trial ID
NCT01307423
Treatments Being Tested
The main aim of this study is to show how well TAK-279 reduces the skin pla...
Status
Completed
Location
Saguaro Dermatology Associates, LLC - Probity - PPDS
Start Date
2023-11-06
Trial ID
NCT06088043
Treatments Being Tested
The primary objective of this study is to evaluate the time to confirmed cl...
Status
Completed
Location
Pinnacle Research Group LLC
Start Date
2020-11-24
Trial ID
NCT04590586
A Phase II, single institution, double blind, randomized, placebo controlle...
Status
Withdrawn
Location
Stanford University School of Medicine
Start Date
2010-09
Trial ID
NCT01204138
Treatments Being Tested
The objective of the study is to assess the superiority of apremilast in co...
Status
Recruiting
Location
Chu Amiens
Start Date
2022-04-10
Trial ID
NCT04227314
Treatments Being Tested
A phase 4 multicenter, randomized, placebo-controlled Study evaluating the ...
Status
Unknown
Location
KSSG
Start Date
2018-06
Trial ID
NCT03553433
Treatments Being Tested
The purpose of this study was to test if the drug apremilast was safe, if i...
Status
Completed
Location
Associates In Research Inc
Start Date
2008-09-01
Trial ID
NCT00773734
Treatments Being Tested
This study is conducted to determine the side effects related to LY2775240 ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Start Date
2016-12
Trial ID
NCT02963779
Treatments Being Tested
The purpose of this study is to determine whether apremilast is safe and ef...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2010-09-30
Trial ID
NCT01212770
Treatments Being Tested